RNF114 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.0810002306132E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.72259999597912E-08 |
Normal-vs-Stage2 |
2.16819999999673E-05 |
Normal-vs-Stage3 |
1.01219999049107E-09 |
Normal-vs-Stage4 |
1.76007999999062E-05 |
Stage1-vs-Stage2 |
3.921800E-01 |
Stage1-vs-Stage3 |
2.714500E-02 |
Stage1-vs-Stage4 |
5.797200E-01 |
Stage2-vs-Stage3 |
6.337800E-01 |
Stage2-vs-Stage4 |
7.335600E-01 |
Stage3-vs-Stage4 |
3.192600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.47260004190741E-09 |
Normal-vs-AfricanAmerican |
2.55320000031034E-07 |
Normal-vs-Asian |
5.968600E-01 |
Caucasian-vs-AfricanAmerican |
3.331400E-01 |
Caucasian-vs-Asian |
1.049820E-01 |
AfricanAmerican-vs-Asian |
4.968000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.64429994462279E-09 |
Normal-vs-Female |
9.72049996050828E-09 |
Male-vs-Female |
4.717800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.283440E-03 |
Normal-vs-Age(41-60Yrs) |
7.96620003296056E-09 |
Normal-vs-Age(61-80Yrs) |
4.77100003948294E-09 |
Normal-vs-Age(81-100Yrs) |
3.282800E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.588000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.869400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.457600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.027000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.404400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.640800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.778400E-02 |
Normal-vs-Grade 2 |
1.20519999535773E-08 |
Normal-vs-Grade 3 |
2.02240000302112E-08 |
Normal-vs-Grade 4 |
9.03210000013921E-07 |
Grade 1-vs-Grade 2 |
4.296200E-01 |
Grade 1-vs-Grade 3 |
1.565780E-01 |
Grade 1-vs-Grade 4 |
7.960000E-02 |
Grade 2-vs-Grade 3 |
3.906600E-01 |
Grade 2-vs-Grade 4 |
1.817830E-01 |
Grade 3-vs-Grade 4 |
4.222600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.22519999995663E-06 |
Normal-vs-ccB subtype |
5.60729995768838E-09 |
ccA subtype-vs-ccB subtype |
6.801700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.31709998252694E-09 |
Normal-vs-N1 |
1.595400E-01 |
N0-vs-N1 |
6.441400E-01 |
|
|